Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Maxim Group Downgrades Cyclo Therapeutics (CYTH) to Hold
-
Maxim Group Starts Iconix Brand (ICON) at Buy
-
5E Advanced Materials (FEAM) Announces Pricing of $4.0 Million Registered Direct Offering and Execution of Debt Commitment Letter to Issue $6.0 Million of Senior Secured Convertible Notes
-
5E Advanced Materials Announces Pricing of $4.0 Million Registered Direct Offering and Execution of Debt Commitment Letter to Issue $6.0 Million of Senior Secured Convertible Notes
-
Maxim Group Starts Light & Wonder (LNW) at Buy
-
Maxim Group Starts JAKKS Pacific (JAKK) at Buy
-
Farmmi Inc. (FAMI) Prices $1.0 Million Registered Direct Offering
-
Farmmi Announces Pricing of $1.0 Million Registered Direct Offering
-
Draganfly Announces Closing of US$2.0 Million Registered Direct Offering
-
Dermata Therapeutics In (DRMA) PT Lowered to $6 at Maxim Group
-
Draganfly Inc (DPRO) Prices 16.67M Unit Offering at $0.12/unit
-
Draganfly Announces Pricing of US$2.0 Million Registered Direct Offering
-
Moleculin Announces Closing of up to $16.5 Million Public Offering
-
LeddarTech Announces Up to US$9.0 Million Financing and US$1.5 Million of Convertible Note Conversions Above Market at US$2.00 Per Share
-
LM Funding America (LMFA) Prices $2.6M Share and Warrant Offering at $2.93/sh
-
LM Funding America Announces Pricing of Registered Direct Offering for Aggregate Gross Proceeds of $2.6 Million
-
Star Equity Holdings, Inc. (STRR) PT Lowered to $8 at Maxim Group
-
Ondas Holdings Inc. (ONDS) PT Lowered to $1.50 at Maxim Group
-
Dolphin Entertainment (DLPN) PT Lowered to $4 at Maxim Group
-
ReShape Lifesciences® Reports Second Quarter Ended June 30, 2024 Financial Results and Provides Corporate Update
-
Safe and Green Development (SGD) Secures $10M Strategic Investment from Arena Investors
-
Safe and Green Development Corporation Secures Strategic Investment of up to $10 Million from Arena Investors
-
Draganfly Announces 30% Quarter Over Quarter Revenue Increase with Second Quarter Results for 2024
-
Spartan Capital Securities, LLC and B2i Digital Announce the Spartan Capital Investor Conference 2024
-
CV Sciences, Inc. Reports Second Quarter 2024 Financial Results
-
Citius Pharmaceuticals Completes Merger of Subsidiary with TenX Keane to form Citius Oncology, Inc.
-
TenX Keane Acquisition Addresses Trading Halt, Continues Towards Closing of Business Combination, and Provides Market Update
-
Iterum Therapeutics Announces Expiration and Results of Rights Offering
-
Beneficient Joins B2i Digital Family of Featured Companies
-
Spartan Capital Securities, LLC and B2i Digital Announce the Spartan Capital Investor Conference 2024
-
Spartan Capital Securities, LLC and B2i Digital Announce the Spartan Capital Investor Conference 2024
-
Citius Pharmaceuticals (CTXR) Announces TenX Keane Shareholder Approval of Merger with Citius Oncology
-
TenX Keane Acquisition Shareholders Approve Previously Announced Merger to Form Citius Oncology, Inc., a Publicly Listed Subsidiary of Citius Pharmaceuticals
-
Citius Pharmaceuticals Announces TenX Keane Shareholder Approval of Merger with Citius Oncology, Inc.
-
SELLAS Life Sciences (SLS) Announces 15.85M Share Offering at $1.325/sh
-
SELLAS Life Sciences Announces $21.0 Million Registered Direct Offering Priced at a Premium to Market
-
Roadzen Inc. (RDZN) PT Lowered to $7 at Maxim Group
-
Heart Test Laboratories Inc. (HSCS) PT Lowered to $12 at Maxim Group
-
BWX Technologies (BWXT) PT Lowered to $113 at Maxim Group
-
Beyond Inc. (BYON) PT Lowered to $33 at Maxim Group
-
Chemomab Therapeutics Announces Closing of $10 Million Private Placement
-
OrangeKloud Technology Inc. Announces Closing of $13.1 Million Initial Public Offering
-
CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering
-
Chemomab Therapeutics (CMMB) Announces $10 Million Private Placement
-
Chemomab Therapeutics Announces $10 Million Private Placement
-
OrangeKloud Technology (ORKT) Prices 2.75M Share IPO at $4.75/sh
-
OrangeKloud Technology Inc. Announces Pricing of $13.1 Million Initial Public Offering
-
NBA signs broadcasting deal with Disney, Amazon, Comcast worth $77 billion
-
Azitra, Inc (AZTR) Prices 6.66M Share Offering at $1.50/sh
-
Azitra, Inc. Announces Pricing of $10.0 Million Public Offering

